SuperworthSonoma Pharmaceuticals shares outstanding SNOA
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 3.8M
- On a year earlier
- +134.4%
- more shares
Sonoma Pharmaceuticals had 3.8M diluted shares outstanding on average in Q1 FY27, the quarter to Jun 30, 2026.
That is 134.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2026 | 1.7M | +7% |
| FY2025 | 1.6M | +111% |
| FY2024 | 769K | +259% |
| FY2023 | 214K | +38% |
| FY2022 | 155K | +49% |
| FY2021 | 104.3K | +17% |
| FY2020 | 88.8K | +35% |
| FY2019 | 65.9K | +131% |
| FY2018 | 28.5K | +20% |
| FY2017 | 23.7K | +20% |
| FY2016 | 19.9K | +35% |
| FY2015 | 14.7K | +76% |
| FY2014 | 8.3K | +33% |
| FY2013 | 6.2K | +36% |
| FY2012 | 4.6K | +9% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q1 FY27 | 3.8M | +134% | |
| Q4 FY26 | 1.7M | +7% | |
| Q3 FY26 | 1.7M | +17% | |
| Q2 FY26 | 1.6M | +59% | |
| Q1 FY26 | 1.6M | +93% | |
| Q4 FY25 | 1.6M | +111% | |
| Q3 FY25 | 1.5M | +168% | |
| Q2 FY25 | 1M | +301% | |
| Q1 FY25 | 851K | +245% | |
| Q4 FY24 | 769K | +259% | |
| Q3 FY24 | 546K | +251% | |
| Q2 FY24 | 258K | +66% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Sonoma Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.